ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell and Gene Therapy CDMO Services Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-25R16752
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell and Gene Therapy CDMO Services Market Research Report 2024
BUY CHAPTERS

Global Cell and Gene Therapy CDMO Services Market Research Report 2024

Code: QYRE-Auto-25R16752
Report
April 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Catalent
Lonza
Thermo Fisher
WuXi AppTec
Charles River
OBiO Technology
GenScript
Esco
Nikon
Fujifilm
Pharmaron
Porton
Medicilon
Joinn Laboratories
Sofpromed
RoslinCT
BioCentriq
Miltenyi Bioindustry
OxfordBioMedica
BrammerBio
CELLfor CURE
eXmoor
OmniaBio
PolTREG

Cell and Gene Therapy CDMO Services Market Size

The global Cell and Gene Therapy CDMO Services market was valued at US$ 5598 million in 2023 and is anticipated to reach US$ 42510 million by 2030, witnessing a CAGR of 32.9% during the forecast period 2024-2030.

Cell and Gene Therapy CDMO Services Market

Cell and Gene Therapy CDMO Services Market

Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) services involve companies providing specialized expertise and infrastructure for the development, manufacturing, and commercialization of cell and gene therapy products on behalf of biopharmaceutical companies. These services encompass a range of activities, including process development, analytical testing, regulatory support, and manufacturing at various scales, from preclinical to commercial production. CDMOs play a critical role in accelerating the translation of cell and gene therapies from research to clinical application by offering tailored solutions to meet the unique requirements of each therapy, ultimately helping to bring innovative treatments to patients more efficiently and effectively.
Due to complex technical mechanisms, high-threshold process development and large-scale production, strict regulatory requirements, and limited industrialization experience, CGT products are more dependent on CDMOs than traditional pharmaceuticals. Its outsourcing penetration rate exceeds 65%, far exceeding 35% of traditional biologics.
Considering that the production of viral vectors as the core involves very complex processes, is extremely difficult, and has a long preparation cycle, it is expected that the outsourcing rate of CGT will remain high in the future.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy CDMO Services.
The Cell and Gene Therapy CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell and Gene Therapy CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell and Gene Therapy CDMO Services Market Report

Report Metric Details
Report Name Cell and Gene Therapy CDMO Services Market
Accounted market size in 2023 US$ 5598 in million
Forecasted market size in 2030 US$ 42510 million
CAGR 32.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Autologous Cell Therapy Products
  • Allogeneic Cell Therapy Products
Segment by Application
  • SMBs
  • Large Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Lonza, Thermo Fisher, WuXi AppTec, Charles River, OxfordBioMedica, BrammerBio, CELLfor CURE, OBiO Technology, GenScript, Esco, Nikon, FUJIFILM, Pharmaron, Porton, Medicilon, JOINN Laboratories, Sofpromed, eXmoor, OmniaBio, RoslinCT, BioCentriq, PolTREG, Miltenyi Bioindustry
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell and Gene Therapy CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cell and Gene Therapy CDMO Services Market growing?

Ans: The Cell and Gene Therapy CDMO Services Market witnessing a CAGR of 32.9% during the forecast period 2024-2030.

What is the Cell and Gene Therapy CDMO Services Market size in 2030?

Ans: The Cell and Gene Therapy CDMO Services Market size in 2030 will be US$ 42510 million.

Who are the main players in the Cell and Gene Therapy CDMO Services Market report?

Ans: The main players in the Cell and Gene Therapy CDMO Services Market are Catalent, Lonza, Thermo Fisher, WuXi AppTec, Charles River, OxfordBioMedica, BrammerBio, CELLfor CURE, OBiO Technology, GenScript, Esco, Nikon, FUJIFILM, Pharmaron, Porton, Medicilon, JOINN Laboratories, Sofpromed, eXmoor, OmniaBio, RoslinCT, BioCentriq, PolTREG, Miltenyi Bioindustry

What are the Application segmentation covered in the Cell and Gene Therapy CDMO Services Market report?

Ans: The Applications covered in the Cell and Gene Therapy CDMO Services Market report are SMBs, Large Companies

What are the Type segmentation covered in the Cell and Gene Therapy CDMO Services Market report?

Ans: The Types covered in the Cell and Gene Therapy CDMO Services Market report are Autologous Cell Therapy Products, Allogeneic Cell Therapy Products

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Autologous Cell Therapy Products
1.2.3 Allogeneic Cell Therapy Products
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy CDMO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy CDMO Services Market Perspective (2019-2030)
2.2 Global Cell and Gene Therapy CDMO Services Growth Trends by Region
2.2.1 Global Cell and Gene Therapy CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell and Gene Therapy CDMO Services Historic Market Size by Region (2019-2024)
2.2.3 Cell and Gene Therapy CDMO Services Forecasted Market Size by Region (2025-2030)
2.3 Cell and Gene Therapy CDMO Services Market Dynamics
2.3.1 Cell and Gene Therapy CDMO Services Industry Trends
2.3.2 Cell and Gene Therapy CDMO Services Market Drivers
2.3.3 Cell and Gene Therapy CDMO Services Market Challenges
2.3.4 Cell and Gene Therapy CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy CDMO Services Players by Revenue
3.1.1 Global Top Cell and Gene Therapy CDMO Services Players by Revenue (2019-2024)
3.1.2 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy CDMO Services Revenue
3.4 Global Cell and Gene Therapy CDMO Services Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy CDMO Services Revenue in 2023
3.5 Global Key Players of Cell and Gene Therapy CDMO Services Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy CDMO Services, Product and Application
3.7 Global Key Players of Cell and Gene Therapy CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy CDMO Services Breakdown Data by Type
4.1 Global Cell and Gene Therapy CDMO Services Historic Market Size by Type (2019-2024)
4.2 Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Type (2025-2030)
5 Cell and Gene Therapy CDMO Services Breakdown Data by Application
5.1 Global Cell and Gene Therapy CDMO Services Historic Market Size by Application (2019-2024)
5.2 Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell and Gene Therapy CDMO Services Market Size (2019-2030)
6.2 North America Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
6.4 North America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy CDMO Services Market Size (2019-2030)
7.2 Europe Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
7.4 Europe Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy CDMO Services Market Size (2019-2030)
9.2 Latin America Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
9.4 Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Cell and Gene Therapy CDMO Services Introduction
11.1.4 Catalent Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Cell and Gene Therapy CDMO Services Introduction
11.2.4 Lonza Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Introduction
11.3.4 Thermo Fisher Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.3.5 Thermo Fisher Recent Development
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Details
11.4.2 WuXi AppTec Business Overview
11.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Introduction
11.4.4 WuXi AppTec Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.4.5 WuXi AppTec Recent Development
11.5 Charles River
11.5.1 Charles River Company Details
11.5.2 Charles River Business Overview
11.5.3 Charles River Cell and Gene Therapy CDMO Services Introduction
11.5.4 Charles River Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.5.5 Charles River Recent Development
11.6 OxfordBioMedica
11.6.1 OxfordBioMedica Company Details
11.6.2 OxfordBioMedica Business Overview
11.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Introduction
11.6.4 OxfordBioMedica Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.6.5 OxfordBioMedica Recent Development
11.7 BrammerBio
11.7.1 BrammerBio Company Details
11.7.2 BrammerBio Business Overview
11.7.3 BrammerBio Cell and Gene Therapy CDMO Services Introduction
11.7.4 BrammerBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.7.5 BrammerBio Recent Development
11.8 CELLfor CURE
11.8.1 CELLfor CURE Company Details
11.8.2 CELLfor CURE Business Overview
11.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Introduction
11.8.4 CELLfor CURE Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.8.5 CELLfor CURE Recent Development
11.9 OBiO Technology
11.9.1 OBiO Technology Company Details
11.9.2 OBiO Technology Business Overview
11.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Introduction
11.9.4 OBiO Technology Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.9.5 OBiO Technology Recent Development
11.10 GenScript
11.10.1 GenScript Company Details
11.10.2 GenScript Business Overview
11.10.3 GenScript Cell and Gene Therapy CDMO Services Introduction
11.10.4 GenScript Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.10.5 GenScript Recent Development
11.11 Esco
11.11.1 Esco Company Details
11.11.2 Esco Business Overview
11.11.3 Esco Cell and Gene Therapy CDMO Services Introduction
11.11.4 Esco Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.11.5 Esco Recent Development
11.12 Nikon
11.12.1 Nikon Company Details
11.12.2 Nikon Business Overview
11.12.3 Nikon Cell and Gene Therapy CDMO Services Introduction
11.12.4 Nikon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.12.5 Nikon Recent Development
11.13 FUJIFILM
11.13.1 FUJIFILM Company Details
11.13.2 FUJIFILM Business Overview
11.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Introduction
11.13.4 FUJIFILM Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.13.5 FUJIFILM Recent Development
11.14 Pharmaron
11.14.1 Pharmaron Company Details
11.14.2 Pharmaron Business Overview
11.14.3 Pharmaron Cell and Gene Therapy CDMO Services Introduction
11.14.4 Pharmaron Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.14.5 Pharmaron Recent Development
11.15 Porton
11.15.1 Porton Company Details
11.15.2 Porton Business Overview
11.15.3 Porton Cell and Gene Therapy CDMO Services Introduction
11.15.4 Porton Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.15.5 Porton Recent Development
11.16 Medicilon
11.16.1 Medicilon Company Details
11.16.2 Medicilon Business Overview
11.16.3 Medicilon Cell and Gene Therapy CDMO Services Introduction
11.16.4 Medicilon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.16.5 Medicilon Recent Development
11.17 JOINN Laboratories
11.17.1 JOINN Laboratories Company Details
11.17.2 JOINN Laboratories Business Overview
11.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Introduction
11.17.4 JOINN Laboratories Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.17.5 JOINN Laboratories Recent Development
11.18 Sofpromed
11.18.1 Sofpromed Company Details
11.18.2 Sofpromed Business Overview
11.18.3 Sofpromed Cell and Gene Therapy CDMO Services Introduction
11.18.4 Sofpromed Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.18.5 Sofpromed Recent Development
11.19 eXmoor
11.19.1 eXmoor Company Details
11.19.2 eXmoor Business Overview
11.19.3 eXmoor Cell and Gene Therapy CDMO Services Introduction
11.19.4 eXmoor Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.19.5 eXmoor Recent Development
11.20 OmniaBio
11.20.1 OmniaBio Company Details
11.20.2 OmniaBio Business Overview
11.20.3 OmniaBio Cell and Gene Therapy CDMO Services Introduction
11.20.4 OmniaBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.20.5 OmniaBio Recent Development
11.21 RoslinCT
11.21.1 RoslinCT Company Details
11.21.2 RoslinCT Business Overview
11.21.3 RoslinCT Cell and Gene Therapy CDMO Services Introduction
11.21.4 RoslinCT Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.21.5 RoslinCT Recent Development
11.22 BioCentriq
11.22.1 BioCentriq Company Details
11.22.2 BioCentriq Business Overview
11.22.3 BioCentriq Cell and Gene Therapy CDMO Services Introduction
11.22.4 BioCentriq Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.22.5 BioCentriq Recent Development
11.23 PolTREG
11.23.1 PolTREG Company Details
11.23.2 PolTREG Business Overview
11.23.3 PolTREG Cell and Gene Therapy CDMO Services Introduction
11.23.4 PolTREG Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.23.5 PolTREG Recent Development
11.24 Miltenyi Bioindustry
11.24.1 Miltenyi Bioindustry Company Details
11.24.2 Miltenyi Bioindustry Business Overview
11.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Introduction
11.24.4 Miltenyi Bioindustry Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.24.5 Miltenyi Bioindustry Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Catalent
Lonza
Thermo Fisher
WuXi AppTec
Charles River
OBiO Technology
GenScript
Esco
Nikon
Fujifilm
Pharmaron
Porton
Medicilon
Joinn Laboratories
Sofpromed
RoslinCT
BioCentriq
Miltenyi Bioindustry
OxfordBioMedica
BrammerBio
CELLfor CURE
eXmoor
OmniaBio
PolTREG
List of Tables
 Table 1. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Autologous Cell Therapy Products
 Table 3. Key Players of Allogeneic Cell Therapy Products
 Table 4. Global Cell and Gene Therapy CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Cell and Gene Therapy CDMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Cell and Gene Therapy CDMO Services Market Share by Region (2019-2024)
 Table 8. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Cell and Gene Therapy CDMO Services Market Share by Region (2025-2030)
 Table 10. Cell and Gene Therapy CDMO Services Market Trends
 Table 11. Cell and Gene Therapy CDMO Services Market Drivers
 Table 12. Cell and Gene Therapy CDMO Services Market Challenges
 Table 13. Cell and Gene Therapy CDMO Services Market Restraints
 Table 14. Global Cell and Gene Therapy CDMO Services Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Cell and Gene Therapy CDMO Services Market Share by Players (2019-2024)
 Table 16. Global Top Cell and Gene Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2023)
 Table 17. Ranking of Global Top Cell and Gene Therapy CDMO Services Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy CDMO Services Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Cell and Gene Therapy CDMO Services, Headquarters and Area Served
 Table 20. Global Key Players of Cell and Gene Therapy CDMO Services, Product and Application
 Table 21. Global Key Players of Cell and Gene Therapy CDMO Services, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Type (2019-2024)
 Table 25. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Type (2025-2030)
 Table 27. Global Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Application (2019-2024)
 Table 29. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Application (2025-2030)
 Table 31. North America Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Catalent Company Details
 Table 47. Catalent Business Overview
 Table 48. Catalent Cell and Gene Therapy CDMO Services Product
 Table 49. Catalent Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 50. Catalent Recent Development
 Table 51. Lonza Company Details
 Table 52. Lonza Business Overview
 Table 53. Lonza Cell and Gene Therapy CDMO Services Product
 Table 54. Lonza Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 55. Lonza Recent Development
 Table 56. Thermo Fisher Company Details
 Table 57. Thermo Fisher Business Overview
 Table 58. Thermo Fisher Cell and Gene Therapy CDMO Services Product
 Table 59. Thermo Fisher Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 60. Thermo Fisher Recent Development
 Table 61. WuXi AppTec Company Details
 Table 62. WuXi AppTec Business Overview
 Table 63. WuXi AppTec Cell and Gene Therapy CDMO Services Product
 Table 64. WuXi AppTec Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 65. WuXi AppTec Recent Development
 Table 66. Charles River Company Details
 Table 67. Charles River Business Overview
 Table 68. Charles River Cell and Gene Therapy CDMO Services Product
 Table 69. Charles River Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 70. Charles River Recent Development
 Table 71. OxfordBioMedica Company Details
 Table 72. OxfordBioMedica Business Overview
 Table 73. OxfordBioMedica Cell and Gene Therapy CDMO Services Product
 Table 74. OxfordBioMedica Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 75. OxfordBioMedica Recent Development
 Table 76. BrammerBio Company Details
 Table 77. BrammerBio Business Overview
 Table 78. BrammerBio Cell and Gene Therapy CDMO Services Product
 Table 79. BrammerBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 80. BrammerBio Recent Development
 Table 81. CELLfor CURE Company Details
 Table 82. CELLfor CURE Business Overview
 Table 83. CELLfor CURE Cell and Gene Therapy CDMO Services Product
 Table 84. CELLfor CURE Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 85. CELLfor CURE Recent Development
 Table 86. OBiO Technology Company Details
 Table 87. OBiO Technology Business Overview
 Table 88. OBiO Technology Cell and Gene Therapy CDMO Services Product
 Table 89. OBiO Technology Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 90. OBiO Technology Recent Development
 Table 91. GenScript Company Details
 Table 92. GenScript Business Overview
 Table 93. GenScript Cell and Gene Therapy CDMO Services Product
 Table 94. GenScript Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 95. GenScript Recent Development
 Table 96. Esco Company Details
 Table 97. Esco Business Overview
 Table 98. Esco Cell and Gene Therapy CDMO Services Product
 Table 99. Esco Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 100. Esco Recent Development
 Table 101. Nikon Company Details
 Table 102. Nikon Business Overview
 Table 103. Nikon Cell and Gene Therapy CDMO Services Product
 Table 104. Nikon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 105. Nikon Recent Development
 Table 106. FUJIFILM Company Details
 Table 107. FUJIFILM Business Overview
 Table 108. FUJIFILM Cell and Gene Therapy CDMO Services Product
 Table 109. FUJIFILM Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 110. FUJIFILM Recent Development
 Table 111. Pharmaron Company Details
 Table 112. Pharmaron Business Overview
 Table 113. Pharmaron Cell and Gene Therapy CDMO Services Product
 Table 114. Pharmaron Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 115. Pharmaron Recent Development
 Table 116. Porton Company Details
 Table 117. Porton Business Overview
 Table 118. Porton Cell and Gene Therapy CDMO Services Product
 Table 119. Porton Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 120. Porton Recent Development
 Table 121. Medicilon Company Details
 Table 122. Medicilon Business Overview
 Table 123. Medicilon Cell and Gene Therapy CDMO Services Product
 Table 124. Medicilon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 125. Medicilon Recent Development
 Table 126. JOINN Laboratories Company Details
 Table 127. JOINN Laboratories Business Overview
 Table 128. JOINN Laboratories Cell and Gene Therapy CDMO Services Product
 Table 129. JOINN Laboratories Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 130. JOINN Laboratories Recent Development
 Table 131. Sofpromed Company Details
 Table 132. Sofpromed Business Overview
 Table 133. Sofpromed Cell and Gene Therapy CDMO Services Product
 Table 134. Sofpromed Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 135. Sofpromed Recent Development
 Table 136. eXmoor Company Details
 Table 137. eXmoor Business Overview
 Table 138. eXmoor Cell and Gene Therapy CDMO Services Product
 Table 139. eXmoor Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 140. eXmoor Recent Development
 Table 141. OmniaBio Company Details
 Table 142. OmniaBio Business Overview
 Table 143. OmniaBio Cell and Gene Therapy CDMO Services Product
 Table 144. OmniaBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 145. OmniaBio Recent Development
 Table 146. RoslinCT Company Details
 Table 147. RoslinCT Business Overview
 Table 148. RoslinCT Cell and Gene Therapy CDMO Services Product
 Table 149. RoslinCT Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 150. RoslinCT Recent Development
 Table 151. BioCentriq Company Details
 Table 152. BioCentriq Business Overview
 Table 153. BioCentriq Cell and Gene Therapy CDMO Services Product
 Table 154. BioCentriq Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 155. BioCentriq Recent Development
 Table 156. PolTREG Company Details
 Table 157. PolTREG Business Overview
 Table 158. PolTREG Cell and Gene Therapy CDMO Services Product
 Table 159. PolTREG Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 160. PolTREG Recent Development
 Table 161. Miltenyi Bioindustry Company Details
 Table 162. Miltenyi Bioindustry Business Overview
 Table 163. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product
 Table 164. Miltenyi Bioindustry Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
 Table 165. Miltenyi Bioindustry Recent Development
 Table 166. Research Programs/Design for This Report
 Table 167. Key Data Information from Secondary Sources
 Table 168. Key Data Information from Primary Sources
 Table 169. Authors List of This Report


List of Figures
 Figure 1. Cell and Gene Therapy CDMO Services Picture
 Figure 2. Global Cell and Gene Therapy CDMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Cell and Gene Therapy CDMO Services Market Share by Type: 2023 VS 2030
 Figure 4. Autologous Cell Therapy Products Features
 Figure 5. Allogeneic Cell Therapy Products Features
 Figure 6. Global Cell and Gene Therapy CDMO Services Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Cell and Gene Therapy CDMO Services Market Share by Application: 2023 VS 2030
 Figure 8. SMBs Case Studies
 Figure 9. Large Companies Case Studies
 Figure 10. Cell and Gene Therapy CDMO Services Report Years Considered
 Figure 11. Global Cell and Gene Therapy CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 12. Global Cell and Gene Therapy CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Cell and Gene Therapy CDMO Services Market Share by Region: 2023 VS 2030
 Figure 14. Global Cell and Gene Therapy CDMO Services Market Share by Players in 2023
 Figure 15. Global Top Cell and Gene Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2023)
 Figure 16. The Top 10 and 5 Players Market Share by Cell and Gene Therapy CDMO Services Revenue in 2023
 Figure 17. North America Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 18. North America Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)
 Figure 19. United States Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. Canada Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Europe Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)
 Figure 23. Germany Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. France Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. U.K. Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Italy Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Russia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Nordic Countries Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Cell and Gene Therapy CDMO Services Market Share by Region (2019-2030)
 Figure 31. China Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Japan Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. South Korea Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Southeast Asia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. India Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Australia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Latin America Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)
 Figure 39. Mexico Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Brazil Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)
 Figure 43. Turkey Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Saudi Arabia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. UAE Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Catalent Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 47. Lonza Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 48. Thermo Fisher Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 49. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 50. Charles River Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 51. OxfordBioMedica Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 52. BrammerBio Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 53. CELLfor CURE Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 54. OBiO Technology Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 55. GenScript Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 56. Esco Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 57. Nikon Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 58. FUJIFILM Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 59. Pharmaron Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 60. Porton Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 61. Medicilon Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 62. JOINN Laboratories Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 63. Sofpromed Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 64. eXmoor Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 65. OmniaBio Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 66. RoslinCT Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 67. BioCentriq Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 68. PolTREG Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 69. Miltenyi Bioindustry Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Medical Microbial Incubators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-30W13258
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Cannabinoid Derived Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37I13965
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Drugs for the Treatment of Hemarthrosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-13Q14166
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Drugs to Treat Hyperkalemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28I12677
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions